SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-19-000014
Filing Date
2019-10-09
Accepted
2019-10-09 07:01:01
Documents
2
Period of Report
2019-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201910098k.htm 8-K 28569
2 EXHIBIT 10.1 a20191009ex101.htm EX-10.1 79277
  Complete submission text file 0000819050-19-000014.txt   109082
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 191143689
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences